Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

UBT251

UBT251 Injection Phase II Study (Overweight or Obesity)

The United Bio-Technology (Hengqin) Co · Phase 2 · Completed · Enrollment 205

NCT07177469

ArmPopulationDoseWeeksEstimandWeight change
UBT251 Injection 2.0 mgObesity or overweight2.0 mg24n/rn/r
UBT251 Injection 4.0 mg(ID 0.5 mg)Obesity or overweight0.5 mg24n/rn/r
UBT251 Injection 4.0 mg(ID 1.0 mg)Obesity or overweight1.0 mg24n/rn/r
UBT251 Injection 6.0 mgObesity or overweight6.0 mg24n/rn/r